Key result
Simultaneous genetic deletion of Tbx3 and Tbx5 from the adult murine ventricular conduction system caused 100% mortality within 3 months due to profound conduction slowing and ventricular tachycardia.
Why the study?
TBX3 and TBX5 are required for cardiac conduction system development and associated with human conduction diseases, but their coordinated role in the adult ventricular conduction system remained to be evaluated.
Does conditional deletion of Tbx3 and Tbx5 alter ventricular conduction system function and molecular identity in a murine model?
Does conditional deletion of Tbx3 and Tbx5 alter ventricular conduction system function and molecular identity in a murine model?
Absolute Event Rate: 100% vs 0%
p-value: p=<0.0001
Tbx3 and Tbx5 coordinate to control the molecular fate and function of the ventricular conduction system, providing mechanistic insights into cardiac conduction disorders.
Supports Tbx3/Tbx5 as key regulators of murine conduction identity; leaves open translation to human arrhythmia therapies.
The cardiac conduction system (CCS) orchestrates the electrical impulses that enable coordinated contraction of the cardiac chambers. The T-box transcription factors TBX3 and TBX5 are required for CCS development and associated with overlapping and distinct human CCS diseases. We evaluated the coordinated role of Tbx3 and Tbx5 in the murine ventricular conduction system (VCS). We engineered a compound Tbx3:Tbx5 conditional knockout allele for both genes located in cis on mouse chromosome 5. Conditional deletion of both T-box transcriptional factors in the VCS, using the VCS-specific MinK CreERT2 , caused loss of VCS function and molecular identity. Combined Tbx3 and Tbx5 deficiency in the adult VCS led to conduction defects, including prolonged PR and QRS intervals and elevated susceptibility to ventricular tachycardia. These electrophysiological defects occurred prior to detectable alterations in cardiac contractility or histologic morphology, indicative of a primary conduction system defect. Tbx3:Tbx5 double-knockout VCS cardiomyocytes revealed a transcriptional shift toward non-CCS-specialized working myocardium, indicating a change to their cellular identity. Furthermore, optical mapping revealed a loss of VCS-specific conduction system propagation. Collectively, these findings indicate that Tbx3 and Tbx5 coordinate to control VCS molecular fate and function, with implications for understanding cardiac conduction disorders in humans.
No takes yet. Share an insight, caveat, or question.
Burnicka-Turek et al. (2024) studied Cardiac conduction system function (n=120). VCS-specific Tbx3:Tbx5 double-conditional knockout vs. Littermate controls (Tbx3+/+;Tbx5+/+) was evaluated on Mortality within 3 months post-tamoxifen administration (p=<0.0001). Simultaneous genetic deletion of Tbx3 and Tbx5 from the adult murine ventricular conduction system caused 100% mortality within 3 months due to profound conduction slowing and ventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: